Tag: Motley Fool Australia

  • 2 of the best ASX shares to buy right now

    If you have money to invest into the Australian share market in August, then I think it could be worth splitting these funds evenly across the two ASX shares listed below.

    Here’s why I think they would be great options this month:

    BetaShares Asia Technology Tigers ETF (ASX: ASIA)

    I think that investing into this exchange traded fund could be a great idea. Given its growing middle class, I believe the Asian economy will grow very strongly over the next decade. This could make the BetaShares Asia Technology Tigers ETF a long term market beater. This is because this fund tracks the performance of the 50 largest technology and ecommerce companies that have their main area of business in Asia (excluding Japan). Among its holdings you’ll find the likes of Alibaba, Samsung, and Tencent Holdings. The latter is the owner of the hugely popular WeChat app. It also recently became a major shareholder in buy now pay later juggernaut Afterpay Ltd (ASX: APT).

    CSL Limited (ASX: CSL)

    Due to a recent pullback in this biotherapeutics giant’s shares, they are currently trading at a material discount to their 52-week high. The CSL share price weakness has been caused by concerns over its performance in FY 2021 due to difficulties collecting plasma during the pandemic. These collections are important as they are used to create some of its leading therapies. A shortage of plasma could drive prices higher and lead to margin compression. While this is certainly a risk, I’m optimistic the damage won’t be anywhere near as bad as the market believes. In addition to this, I expect demand for flu vaccines to offset some or even all of any potential weakness. In light of this, I think investors ought to focus on its long term future, which I believe is remarkably positive. This is thanks to its leading therapies, recent acquisitions, and its high level of investment in research and development. The latter is underpinning a pipeline of very lucrative potential future therapies.

    Legendary stock picker names 5 cheap stocks to buy right now

    Motley Fool resident tech stock expert Dr. Anirban Mahanti has stumbled upon five stocks he believes could be some of the greatest discoveries of his investing career.

    These little-known ASX stocks are growing like gangbusters, yet you can buy them today for less than $5 a share. Click here to learn more.

    See these 5 cheap stocks

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of and has recommended BetaShares Asia Technology Tigers ETF. The Motley Fool Australia owns shares of AFTERPAY T FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 2 of the best ASX shares to buy right now appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2DriE1q

  • 3 ASX shares poised for huge growth over the next year

    Rocket soaring through sky

    Rocket soaring through skyRocket soaring through sky

    I believe that ASX growth shares are the best way to invest in 2020.

    There is a lot of uncertainty at the moment due to COVID-19, so I think it makes sense to go for businesses that can deliver good growth in the short-term and the long-term.

    They need to be businesses that could be resilient even in the face of COVID-19 impacts:

    Share 1: Pushpay Holdings Ltd (ASX: PPH)

    Pushpay is one of the best ASX growth shares in my opinion. It facilitates digital giving to not for profits. At this stage its biggest client base and its largest opportunity is the US large and medium sector.

    FY20 was a very strong year for the company with revenue growth of 32% to US$129.8 million. Earnings before interest, tax, depreciation, amortisation and foreign currency (EBITDAF) rose by 1,506% from US$1.6 million to US$25.1 million.

    In FY21 the ASX growth share is expecting EBITDAF to at least double to between US$50 million to US$54 million. The company has regularly achieved its goals for each year. Over the long-term it’s aiming for US$1 billion of revenue from the US church sector.

    Pushpay continues to see an increase in demand for Pushpay’s services. I think COVID-19 is causing Pushpay’s adoption curve to accelerate and its revenue will benefit.

    The ASX growth share increased its guidance a number of times during FY20. I wouldn’t expect the same to happen again, but I think could Pushpay could keep impressing.

    Pushpay is trading at 32x FY22’s estimated earnings.

    Share 2: A2 Milk Company Ltd (ASX: A2M)

    A2 Milk has been one of the best ASX growth shares over the past five years. But I don’t think its growth is suddenly going to stop. I believe A2 Milk is one of the best opportunities within the ASX 100.

    In FY20 the company is expecting revenue growth of at least 30.3%, which is impressive considering the business has been growing strongly for many years already.

    It was good to read that the ASX share is expecting revenue growth in FY20 to be so strong that its earnings before interest, tax, depreciation and amortisation (EBITDA) margin to be between 31% to 32% rather than the medium-term target of 30%.

    I like the 30% EBITDA margin target because it’s a good balance between profitability and investing for future growth.

    It seems like COVID-19 isn’t going away any time soon, so I think A2 Milk could see elevated revenue over FY21 as well.

    The ASX share is slowly but steadily growing its market share in China and the growth of its distribution footprint in the US is also very promising.

    At the current A2 Milk share price it’s trading at 29x FY22’s estimated earnings.

    Share 3: Kogan.com Ltd (ASX: KGN)

    The online retailer has been one of the ASX shares to rebound the strongest after the initial COVID-19 crash.

    But a lot of the resurgent share price performance has been justified with how much its revenue and operating profit has grown over the past few months.

    In its FY20 fourth quarter it said that compared to the prior corresponding period its gross sales rose by more than 95%, its gross profit increased by more than 115% and its adjusted EBITDA grew by 149%. In June 2020 alone Kogan added 109,000 customers.

    This type of growth isn’t likely to suddenly come to a stop. Australians are being urged to avoid crowded places and the shift to online shopping seems like an accelerated shift to ecommerce.

    The Kogan.com share price has risen 281% over the past six months and if it keeps growing at a fast pace then its share price could keep going higher.

    Foolish takeaway

    I think each of these ASX shares will report solid double digit revenue growth in FY21 which will hopefully equate to good profit growth as well. At the current share prices I think Pushpay and A2 Milk could be really good picks today. 

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd and PUSHPAY FPO NZX. The Motley Fool Australia owns shares of A2 Milk. The Motley Fool Australia has recommended Kogan.com ltd and PUSHPAY FPO NZX. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 ASX shares poised for huge growth over the next year appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2DE1r4S

  • Why the Coca-Cola share price and these ASX stocks just got upgraded by brokers to “buy”

    Coca Cola shares

    Coca Cola sharesCoca Cola shares

    Don’t be discouraged by the market sell-off today as there’s still value to be found judging by the latest broker upgrades.

    The S&P/ASX 200 Index (Index:^AXJO) is on track to close the week with a 0.7% loss as it struggles to decisively break above 6,000.

    But the Coca-Cola Amatil Ltd (ASX: CCL) share price is bucking the downtrend on Friday. Shares in the beverage maker jumped 1.8% to $8.49 as we enter the last hour of trade.

    Looking more appetising

    The Coca-Cola share price got a boost after Goldman Sachs upgraded the stock to “buy” from “neutral”.

    The broker turned positive on the underperformer after management posted its latest trading update. Coca-Cola is starting to look compelling after it shed a quarter of its value in 2020 while Goldman became more confident in its outlook.

    “Although there remains risk that earnings momentum stays under downward pressure in the short term due to shutdowns, we are becoming increasingly compelled by the asymmetric opportunity that CCL’s longer-term earnings potential underpins,” said the broker.

    “The line of sight to these future earnings is also underpinned by CCL’s BBB+/A3 credit rating and balance sheet liquidity.”

    Trading at discount to the sector

    Further, Goldman noted that the stock is trading on a CY2022 forecast price-earnings multiple of around 14.5 times.

    This represents a significant discount to the Coles Group Ltd (ASX: COL) share price and Woolworths Group Ltd (ASX: WOW) share price. The supermarkets are on multiples that are well over 20 times each.

    Room to boom

    Another stock that Goldman thinks is too cheap to ignore is the Incitec Pivot Ltd (ASX: IPL) share price.

    The explosives and fertiliser supplier shed a third of its value since January, but things are starting to turn for Incitec.

    For one, poor demand for its explosives from global miners may be about to reverse in the next few months. The broker is expecting the industry to return to growth in FY21 and FY22, particularly for coal miners.

    Free fertiliser

    “While we remain below consensus (FY21E EBITDA -3%) on expectations for muted phosphate pricing, we see compelling risk-reward for IPL shares even in the absence of a sustained DAP recovery,” said Goldman.

    “The stock’s current valuation implies minimal value for the Fertilizers segment on a SOTP basis as well, which we view as overly punitive.”

    Goldman upgraded Incitec to “buy” and lifted its price target on the stock to $2.62 from $2.50 a share.

    Low hanging fruit

    Finally, the Vitalharvest Freehold Trust (ASX: VTH) share price got lifted to “buy” from “hold” by Bell Potter.

    The broker pointed to improving prices for corps that are grown on its properties and its better dividend outlook for the upgrade.

    Costa Group Holdings Ltd (ASX: CGC) rents farms from Vitalharvest to grow citrus fruits like oranges and blueberries.

    Rents to get a boost

    Strong overseas demand for these fruits is helping to push prices higher and Vitalharvest gets paid extra rent if prices of the soft commodities are strong.

    “In addition, while early in the water year, we note that allocation prices in the southern MDB are down 33% YOY in Jul’20, which would imply a lower cost for unowned water for the 2020/21 citrus season,” said Bell Potter.

    The broker’s 12-month price target on the stock is $0.84 a share.

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Brendon Lau owns shares of Woolworths Limited and COSTA GRP FPO. Connect with me on Twitter @brenlau.

    The Motley Fool Australia owns shares of and has recommended COSTA GRP FPO. The Motley Fool Australia owns shares of COLESGROUP DEF SET and Woolworths Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why the Coca-Cola share price and these ASX stocks just got upgraded by brokers to “buy” appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2C9Elmc

  • Why the Senex Energy share price climbed 17% in July

    Oil & Gas stocks

    Oil & Gas stocksOil & Gas stocks

    Australian oil and gas explorer and producer Senex Energy Ltd‘s (ASX: SXY) share price gained 17.4% in July, closing the month at 27 cents per share. That far outpaced the gains of the broader All Ordinaries Index (ASX: XAO), which ended last month up 0.9%.

    It’s been rocky

    The Senex Energy share price sank by 63% from 21 February through 23 March when oil prices tumbled because of the global COVID-19 outbreak, although the company rebounded well before crude hit its own low. Brent crude oil plummeted 68% from 20 February before hitting a low of US$19.33 (AU$26.85) per barrel on 21 April.

    Since its 23 March low, Senex Energy’s share price rebounded a whopping 108% by 31 July.

    Despite that phenomenal surge, year-to-date, the company is still down 22% in trading.

    What does Senex Energy do?

    Senex (formerly known as Victoria Petroleum NL) is an Australian oil and natural gas explorer and producer. It operates in leading onshore energy regions in the Surat and Cooper Basins. The company is based in Brisbane and also has office locations in Roma, Wandoan and Adelaide.

    Senex listed on the ASX in 1984.

    Why did the Senex Energy share price rise again in July?

    There’s no way around it. When you’re an oil and gas producer, your share price is closely tied to the price of energy.

    The Senex Energy share price almost certainly benefited from the 4.3% gain in Brent crude prices in July. More importantly, Brent crude prices rebounded 133% since the 21 April low, which continued to offer major tailwinds to energy stocks.

    Senex also reported a major Surat Basin gas reserves upgrade on 14 July. The following day, the company released a positive quarterly report for the period ended June 2020.

    The report indicated total production increased 20% compared to the previous quarter. Senex’s total sales volume also increased 4% while revenue climbed 1%.

    The report highlighted how Senex’s diversified revenue streams and low-cost model enabled the company to deliver operational cash flows despite the low oil prices. Pre-existing agreements and a hedging program helped offset some of the burden from the falling crude prices.

    Senex forecast its earnings before interest, taxation, depreciation, and amortisation (EBITDA) would come in on the higher end of its $45–$55 million guidance range for the 2020 financial year.

    Senex Energy’s share price gained 15% in the five trading days following the release of the quarterly report.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why the Senex Energy share price climbed 17% in July appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/31wej5n

  • 3 outstanding ASX shares to buy in August

    hands holding 5 stars

    hands holding 5 starshands holding 5 stars

    If you’re looking at investing in the share market in August, but you’re not sure where to put your money, I would suggest you consider the high quality shares listed below.

    I believe these companies are well-positioned to generate strong returns for investors over the next decade. Here’s why I would invest in their shares:

    a2 Milk Company Ltd (ASX: A2M)

    The first share to consider buying in August is a2 Milk Company. I think the New Zealand-based fresh milk and infant formula company could be a great long term option. After growing its earnings at an explosive rate over the last few years, I‘m confident its strong form can continue for some time to come. This is thanks to the increasing demand for its infant formula products in the massive China market (and its relatively modest market share), its expanding fresh milk footprint in the United States, and its sizeable cash balance. The latter gives a2 Milk Company the option to look to accelerate its growth in the coming years through potential earnings accretive acquisitions.

    Appen Ltd (ASX: APX)

    Another option to consider is Appen. It is a leading developer of high-quality, human annotated datasets for the machine learning and artificial intelligence markets. It provides the data required to create or improve artificial intelligence machine learning models. This is a vital part of the process, because without quality data a model will never reach its potential. Given the growing importance of machine learning, the increasing amount of money been spent by businesses on it, and Appen’s leading position in the industry, I believe it is well-placed for strong long term growth over the next decade.

    Cochlear Limited (ASX: COH)

    A final share to consider buying in August is Cochlear. I believe the hearing solutions company is well-positioned for strong long term growth thanks to the ageing populations tailwind. By 2050 there are forecast to be 1.5 billion people over the aged of 65. This will be almost triple the number of over 65s in 2010. As hearing tends to fade as we age, I expect this tailwind to drive a sustained increase in demand for its cochlear implantable devices over the next couple of decades.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. The Motley Fool Australia owns shares of A2 Milk and Appen Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 outstanding ASX shares to buy in August appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/33GupMt

  • Kazia Therapeutics share price soars 46% on new drug grant

    Biotechnology graphics

    Biotechnology graphicsBiotechnology graphics

    The Kazia Therapeutics Ltd (ASX: KZA) share price has today smashed its 52-week high on news that the United States Food and Drug Administration (FDA) has awarded a grant for Kazia’s flagship drug. The oncology-focused biotech company has gained 46.83% and is currently trading at 82 cents.

    What does Kazia do?

    Kazia is an Australian oncology company that develops innovative, high impact drugs for cancer. Its lead program is paxalisib, which is being developed to treat glioblastoma, the most common and most aggressive form of primary brain cancer in adults.

    The company is dual listed and also trades on the Nasdaq, with its headquarters in Sydney, Australia. Kazia collaborates with leading scientists, clinicians, and investors around the world to further its products.

    Kazia has stated that while there is some early stage evidence that one of its drugs may have a role to play in coronavirus infections, they do not intend to divert focus away from their core work in oncology. Kazia has advised that COVID-19 has not had an impact on any of its operations, including ongoing clinical trials.

    New grant

    It was announced this morning that the FDA has awarded rare pediatric disease designation (RPDD) to Kazia’s flagship drug paxalisib. It will be used for the treatment of diffuse intrinsic pontine glioma, a rare and highly-aggressive childhood brain cancer. This is a great step forward for the company as with RDPP granted, Kazia may now be eligible to receive a rare pediatric disease priority review voucher (PRV), which bodes well for the Kazia Therapeutics share price.

    A PRV grants the holder an expedited 6-month review of a new drug application by the FDA. PRVs can be sold to other companies and have historically commanded prices between US$68 million and US$350 million. The designation was awarded following positive emerging preclinical data in patients with the disease.

    Shareholders will be eagerly awaiting the initial clinical efficacy data that is expected in the first half of FY21. Positive clinical data may substantially enhance the likelihood of a potential future PRV.

    Foolish takeaway

    The news is excellent for Kazia shareholders, with the Kazia Therapeutics share price today smashing its 52-week high to hit $1 in intraday trade. 

    Nevertheless, while this is good news there is still a lot of work before the drug is market ready and can generate meaningful profits.

    The Kazia Therapeutics share price currently sits at 82 cents, giving the company a market capitalisation of $77.57 million.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Kazia Therapeutics share price soars 46% on new drug grant appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/30CrfYa

  • Why I would buy Megaport and this exciting mid cap ASX share

    Buy Shares

    Buy SharesBuy Shares

    If you’re looking for investment ideas, then I think the mid cap side of the market is a great place to start. This is because I believe there are a number of companies that have the potential to grow at a strong rate over the next decade and provide market-beating returns for investors.

    Two top mid cap ASX shares to consider are listed below. Here’s why I like them:

    Megaport Ltd (ASX: MP1)

    The first mid cap ASX share to look at is Megaport. It is an elasticity connectivity and network services company. This service allows its customers to increase and decrease their available bandwidth in response to their own demand requirements. This means that users can consume the bandwidth they need when they need it, rather than be tied to fixed service levels on long-term and expensive contracts. Demand has been exceptionally strong for Megaport’s services this year, thanks to the accelerating shift to the cloud. The good news is that more and more computer infrastructure is expected to go from local servers to cloud providers like Microsoft’s Azure, Amazon’s AWS, and Google Cloud in the future. I believe Megaport is well-placed to benefit from this trend.

    Pro Medicus Limited (ASX: PME)

    Another mid cap ASX share that I think investors should consider is Pro Medicus. It is a leading provider of a full range of radiology IT software and services to hospitals, imaging centres, and healthcare groups worldwide. One key product in its portfolio is the Visage 7 Enterprise Imaging Platform. Management notes that it enables imaging organisations to do things they have always wanted to do, but never could. It offers immediate differentiation for imaging organisations seeking to leapfrog the status quo of commoditised legacy PACS. Given the quality of its products and its sizeable market opportunity, I believe Pro Medicus is capable of growing its earnings at an above average rate over the next decade.

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends MEGAPORT FPO. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended MEGAPORT FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why I would buy Megaport and this exciting mid cap ASX share appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3fBUbn2

  • Ready for the “80% stock market crash”?

    man with hands on head looking at chart with red downward arrow, stock market crash

    man with hands on head looking at chart with red downward arrow, stock market crashman with hands on head looking at chart with red downward arrow, stock market crash

    I received a question from one of our members the other day.

    It went something like:

    “We stuck in there when markets fell. We’ve ridden the partial recovery. But everyone is saying the markets are going to crash hard next. When do we sell?”

    I saw another headline the other day, from someone predicting an 80% stock market crash.

    Frankly, because I’m greedy, I’d welcome such a crash. I mean the chance to buy a small part of Australia’s best businesses, at 20c on the dollar, because of a short-term market overreaction?

    Sign me up.

    And while I’m at it, I’ll be mortgaging the house, selling the cars and hocking the TV to raise as much cash as I can.

    Not everyone has the same response, however.

    An 80% fall would see many people sell in a fit of panic. The desperation to do something – anything – to make the pain stop would be too great.

    It’s a strange quirk of human nature: When shares go up, there must be a crash around the corner. But when they fall, things are going to keep getting worse.

    Man, talk about seeing the bad side of everything.

    I mean, what are the odds that the ASX, currently at 6,000 points, would be not worth buying at 5,000, 4,000 or 3,000 points?

    Do you really think Woolworths Group Ltd (ASX: WOW), BHP Group Ltd (ASX: BHP), CSL Limited (ASX: CSL) and Telstra Corporation Ltd (ASX: TLS), which investors happily hold at current prices, are worth holding today, but should be mindlessly sold if their prices halved?

    And if they fell 80%?

    I hope, dear Fool, that you’d be filling your boots.

    Oh, sure. I get it.

    We’d all like to sell at the very top, then buy in again at the very bottom.

    I’d also like to believe in the Tooth Fairy, Santa Claus, and that Donald Trump actually understands the graphs he used in his interview this week.

    Instead, though, we’re stuck in this messy, imprecise reality.

    The one that, sans crystal balls, doesn’t give up its secrets – especially about the future.

    So let’s break it down.

    First, people have been predicting 80% falls for decades.

    Yes, decades. 

    Often the same people. Sometimes different ones, but with the same schtick.

    So far, they’ve all been wrong. Oh, and in the meantime, the stock market is up about 18-fold over the past thirty years.

    That’s a helluva gain to miss out on while you waited for the ‘predictions’ to come true, huh?

    Second, 80% falls are, well, exceedingly rare. 

    Third, if everyone knew the market was going to fall 80%, they’d have already sold.

    Now, it’s possible that only you and I know the market is going to fall, because we’re possessed of some special insight. That only the three of us – you, me and the bloke (it’s always a bloke) who made the forecast – know the truth.

    Which is as it may be… but that means not everyone knows, after all.

    Fourth, your brain is messing with you. So is mine. We hear, see and read the one prediction of doom, compared to the dozens and dozens of people who expect something between a tough ride and prosperity, and which one sticks in our minds? Yep, that one guy.

    The one nagging thought, snagged somewhere at the front of our consciousness while the others float by, unremarked upon.

    “What if he’s right,” you think. “I mean, it’s possible.”

    So ask yourself: Did you think “What if he’s right?” after someone else predicted a swift recovery? Or a prolonged period of stagnation, then recovery?

    Probably not. We don’t tend to hang on to those thoughts. It’s the predictions of doom that preoccupy us.

    And it’s not your fault.

    It’s evolution.

    Our brains just aren’t programmed to think that far ahead. 

    Or to think in compound, exponential terms.

    Confronted with decades of compound growth (including many periods of tough times), we don’t think “What if that continues?”, but rather “What if it ends?”.

    And fair enough.

    You won’t get any blame from me.

    But what I will do is invite you to engage the part of our brain that can critically analyse our instinctive responses.

    We instinctively fear the dark, even though we know there’s nothing there.

    We instinctively jump at loud noises, even though we know the cause is almost certainly benign.

    We instinctively mistrust people who are unlike us, even though we know it’s an evolutionary leftover.

    And yes, we instinctively fear market falls, even though we know the overwhelming story of the past century (and more) is that, despite the occasional fall, stock markets tend to go higher.

    (And if your response to that is “Yeah, but what about…?”, I’ll tell you that I understand that response, but you’re likely grabbing for the exception that proves the rule, not something that renders the rule useless.)

    For what it’s worth, I think an 80% fall is remarkably unlikely.

    But far more importantly, it it happens, either one of two things will be true:

    The economy has permanently collapsed, and your dollars will be as useless as your shares (and gold, and bitcoin); or

    It’s a short term overreaction, which either presents a buying opportunity, or is just a tough time to live through, while you wait for sanity to return.

    (And remember, you shouldn’t be investing any money you need in the next 3-5 years, anyway.)

    If Woolies falls 80%, do you really think the company will be serving 80% fewer Australians or making 80% less profit from here until eternity?

    Do you think CSL sells 80% fewer vaccines and blood products, forever?

    Does ResMed Inc (ASX: RMD) lose 80% of its sleep apnoea market?

    Will Telstra be only one-fifth of its current size, permanently?

    Now, ‘predictions’ of an 80% fall make for great headlines. They get tongues wagging, and people worrying.

    Remember last year’s ‘prediction’ of a 50% fall in house prices?

    Or 2016’s forecast of an 80% fall in the share market (sounds familiar, huh?).

    Every single prediction of a cataclysmic market crash since 1932 has been wrong.

    Every. Single. One.

    No, I can’t rule it out. Unlike those people who make their outlandish predictions, I make no silly promises.

    Is it possible? Yep.

    But there are plenty of things that are far more likely that we simply outright ignore in our daily lives, because they’re neither so stark, so seemingly dangerous or so breathlessly reported.

    If I declared myself a weatherman, and told you there was a flash flood coming, you’d want to see both my credentials and my track record, right?

    I’d suggest treating those predictions with the same disdain.

    Fool on!

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Scott Phillips owns shares of Telstra Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool Australia owns shares of Woolworths Limited. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Ready for the “80% stock market crash”? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/31wHFjM

  • 2 safe ASX dividend shares to buy in uncertain times

    Are you looking for safe dividend options during these uncertain times? Then you might want to consider buying the ASX dividend shares listed below.

    I feel confident that they will continue to pay dividends largely as normal for the foreseeable future. Here’s why I would buy them:

    Vanguard Australian Shares High Yield ETF (ASX: VHY)

    The first dividend option for investors to consider buying is this exchange traded fund. As you might have guessed from its name, the Vanguard Australian Shares High Yield ETF has a focus on high yield shares. The fund has invested in 66 of the highest yielding blue chip shares on the Australian share market.

    This includes the likes of BHP Group Ltd (ASX: BHP), the big four banks, Coles Group Ltd (ASX: COL), and telco giant Telstra Corporation Ltd (ASX: TLS). While predicting what dividend it will pay next year is tricky, based on the shares within the fund, I would expect an FY 2021 dividend yield somewhere in the region of 4% to 5%. Another positive with this fund is the diversity it offers investors. No industry accounts for more than 40% of the fund and no single company accounts for more than 10%.

    Wesfarmers Ltd (ASX: WES)

    A final dividend share to consider buying is Wesfarmers. I think the conglomerate is a great option for income investors due to the quality and diversity of its portfolio. Another positive is management’s long track record of making earnings accretive acquisitions. This could come into play in the near future given the sizeable amount of cash sitting on its balance sheet following the sell down of its stake in supermarket giant Coles earlier this year.

    All in all, I believe the conglomerate is well-positioned to deliver solid earnings and dividend growth over the next decade. And based on the current Wesfarmers share price, I estimate that it provides investors with an FY 2021 fully franked ~3.2% dividend yield.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool Australia owns shares of COLESGROUP DEF SET and Wesfarmers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 2 safe ASX dividend shares to buy in uncertain times appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2XB8n9I

  • Future Generation LICs grow dividends in June result

    Child investing

    Child investingChild investing

    The listed investment companies (LICs) of Future Generation Investment Company Ltd (ASX: FGX) and Future Generation Global Invstmnt Co Ltd (ASX: FGG) have grown their dividends in the June 2020 results.

    The Future Generation companies are LICs with two main goals. The first goal is to donate 1% of net assets each year to youth charities and youth mental health charities. They can do this by charging shareholders no management fees. The fund managers that the LICs invests with also don’t charge management fees – they work for free. The other goal is to generate returns for shareholders. 

    Future Generation Australia HY20 result

    Future Generation Australia reported that over the six months to 30 June 2020, its portfolio’s decline of 7.1% outperformed the S&P/ASX All Ordinaries Accumulation Index by 3.3% (the index dropped 10.4%) which included the COVID-19 crash.

    Over the past 12 months the LIC’s negative 1.2% return outperformed the index by 6%. Since inception the Future Generation Australia portfolio has grown by an average of 7.3% per annum, outperforming the index by 1.8% per annum. The outperformance was delivered with less volatility.

    The board decided to increase its interim dividend by 8.3% to 2.6 cents per share. The LIC had an estimated profit reserve of 8.6 cents per share at 30 June 2020. The LIC was able to fund this dividend announcement thanks to the profit reserve. The Future Generation share price is up almost 3% in reaction to the announcement.

    At the current Future Generation Australia share price of $1.05, it offers a fully franked dividend yield of 5% or 7% when grossed-up to include the franking credits.

    Some of the charities currently supported include: Act For Kids, Australian Children’s Music Foundation, Australian Indigenous Education Foundation, DEBRA Australia, Diabetes Kids Fund, Giant Steps, Lighthouse Foundation, Mirabel Foundation, Raise Foundation, United Way Australia, Variety and Youth Off The Streets.

    This year the LIC will invest $4.8 million into charities, which will bring the total charitable donations since inception to $21.4 million.

    At the current Future Generation Australia share price it’s trading at a 8.5% discount to the net tangible assets (NTA) at 30 June 2020.

    Future Generation Global HY20 result

    Future Generation Global reported that its portfolio’s return of 0.3% outperformed the MSCI AC World Index’s (AUD) return of negative 4.4% by 4.7%. Over the past year the global LIC’s 7.5% portfolio return outperformed the index by 3.6%.

    The leadership was pleased to preserve shareholder capital in a highly volatile period.

    Since inception, the LIC’s average portfolio return per annum of 9.2% was 0.3% per annum better than the index.

    The board of Future Generation Global announced a 33% increase to its dividend to 2 cents per share. This was achieved by tapping into the profit reserve as well as the solid outperformance achieved in recent times.

    The Future Generation Global share price is up almost 1% in reaction to the announcement.

    If the LIC were to pay 2 cents per share every 12 months going forwards, it would have a grossed-up dividend yield of 2.3% based on the current Future Generation Global share price.

    Some of the current youth mental charities currently supported are: Black Dog Institute, Brain and Mind Centre, Butterfly Foundation for Eating Disorders, Kids Helpline, Orygen – the National Centre of Excellence in Youth Mental Health, ReachOut Australia, SANE Australia and Youth Focus.

    This year the global LIC will invest $5.7 million, which will bring total donations since inception to $19.7 million.

    At the current Future Generation Global share price it’s trading at a 17% discount to the June 2020 NTA.

    Foolish takeaway

    The share prices of both LICs have risen in reaction this result. Outperformance and an increased dividend have been welcomed in these difficult times and investors clearly thought that both were opportunities after today’s result announcements. 

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    The post Future Generation LICs grow dividends in June result appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2F0K9zt